Business Insight: A Look at Cambrex
By Durham Chamber of Commerce / Published 07.09.20Back to Feed
Durham County, North Carolina is renowned as one of the nation’s leading life sciences hubs, with over 300 biotech companies represented. With growing healthcare needs—particularly amidst the current pandemic, it is quite possible our state could be among those that deliver solutions to address this crisis. One local company that is helping address the various healthcare needs across our nation, is Cambrex, a small molecule company providing drug substance, drug product, and a wide range of analytical services across the entire drug lifecycle.
While Cambrex may not be a household name, the work they do impacts our everyday lives, as a leading contract development and manufacturing organization (CDMO) that provides products and services to the pharmaceutical industry. So, there’s a chance that Cambrex may have had a role in delivering the prescription medicine that you or someone you know may rely on to improve or maintain quality of life.
The process to develop drug therapy is a long and complex one, which requires highly specialized skills and a focus on patient safety, a process Cambrex knows well, and is committed to. In the last four years, Cambrex has grown with the acquisitions of Pharmacore, Halo Pharma and Avista Pharma Solutions to deliver a full array of products and services from early stage development to finished goods and establish itself as a formidable end-to-end service provider. And in April 2020, Cambrex announced the expansion of its Durham facility to support additional analytical development and cGMP testing capability.
“As leading provider of contract development and analytical services, the recent biopharmaceutical expansion at our Durham facility enables our team of experts to now offer development and cGMP testing services to support a range of biological drugs”, said Dr. Daniel Kirschner, Senior Director, Cambrex Durham. “We remain committed to adopting the best-in-class technologies and anticipate market demand so that our customers have access to these services when they need them. Our comprehensive expertise, coupled with a transparent, safety-driven approach to implementing the new equipment, allow the Cambrex team to better serve customers across the lifecycle of their drug’s development.”
The Durham facility, now a center of excellence in analytics for the last 18 months, employs 130 of Cambrex’s 2100 total workforce in North America and Europe. Partnership, expertise, and client-focus are cornerstones of the company’s culture. “We are the experts you’ll enjoy working with.” For more information, visit http://www.cambrex.com/